JPH06100427A - Agent for preventing chapped skin - Google Patents
Agent for preventing chapped skinInfo
- Publication number
- JPH06100427A JPH06100427A JP4273398A JP27339892A JPH06100427A JP H06100427 A JPH06100427 A JP H06100427A JP 4273398 A JP4273398 A JP 4273398A JP 27339892 A JP27339892 A JP 27339892A JP H06100427 A JPH06100427 A JP H06100427A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- extract
- water
- preventing
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010040849 Skin fissures Diseases 0.000 title abstract 2
- 239000000284 extract Substances 0.000 claims abstract description 9
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 235000013601 eggs Nutrition 0.000 claims description 7
- 206010013786 Dry skin Diseases 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 16
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract description 9
- 239000002537 cosmetic Substances 0.000 abstract description 9
- 229920002674 hyaluronan Polymers 0.000 abstract description 9
- 229960003160 hyaluronic acid Drugs 0.000 abstract description 9
- 108010003272 Hyaluronate lyase Proteins 0.000 abstract description 7
- 102000001974 Hyaluronidases Human genes 0.000 abstract description 7
- 239000003795 chemical substances by application Substances 0.000 abstract description 7
- 229960002773 hyaluronidase Drugs 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 5
- 239000003921 oil Substances 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 238000000605 extraction Methods 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 abstract description 3
- 230000037303 wrinkles Effects 0.000 abstract description 3
- 241000218218 Ficus <angiosperm> Species 0.000 abstract description 2
- 239000012190 activator Substances 0.000 abstract description 2
- 239000002932 luster Substances 0.000 abstract description 2
- 239000003960 organic solvent Substances 0.000 abstract description 2
- 239000007787 solid Substances 0.000 abstract description 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000003906 humectant Substances 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- -1 for example Substances 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000003449 preventive effect Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 238000007788 roughening Methods 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 235000011076 sorbitan monostearate Nutrition 0.000 description 3
- 239000001587 sorbitan monostearate Substances 0.000 description 3
- 229940035048 sorbitan monostearate Drugs 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000016127 added sugars Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N beta-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は安全性が高い肌荒れ防止
剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a highly safe skin roughening preventive agent.
【0002】[0002]
【従来の技術】肌荒れの原因には種々考えられるが、そ
の一つとして脂質の酸化がある。現在、主として利用さ
れている酸化防止剤としては、ブチルヒドロキシアンソ
ニール(BHA)、ブチルヒドロキシトルエン(BH
T)、ビタミンEやその誘導体がある。BHAやBHT
は合成品である。現在一般的な常識として、合成品の使
用に関して長期間の使用による安全性の保証がないとし
て厳しい非難があり、実際の法規制でも使用が甚だしく
規制されつつある。また、ビタミンEやその誘導体は酸
化防止作用が弱く、天然物で強い酸化防止作用のある物
質が望まれている。There are various possible causes of rough skin, one of which is oxidation of lipids. At present, butylhydroxyanthony (BHA) and butylhydroxytoluene (BH) are mainly used as antioxidants.
T), vitamin E and its derivatives. BHA and BHT
Is a synthetic product. As a general common sense nowadays, there is a harsh criticism regarding the use of synthetic products because there is no guarantee of safety through long-term use, and the use is being severely regulated even by actual legal regulations. In addition, vitamin E and its derivatives have a weak antioxidant action, and a substance that is a natural product and has a strong antioxidant action is desired.
【0003】また、ヒアルロン酸も肌荒れに関与してい
ると考えられる。ヒアルロニダーゼは、生体中に広く分
布し、皮膚にも存在する酵素で、その名の通りヒアルロ
ン酸を分解する。ヒアルロン酸はβ−D−N−アセチル
グルコサミンとβ−D−グルクロン酸が交互に結合した
直鎖状の高分子多糖で、コンドロイチン硫酸などととも
に哺乳動物の結合組織に広く存在するグリコサミノグル
カンの一種である。Hyaluronic acid is also considered to be involved in rough skin. Hyaluronidase is an enzyme that is widely distributed in the living body and is also present in the skin. As its name implies, it decomposes hyaluronic acid. Hyaluronic acid is a linear polymer polysaccharide in which β-D-N-acetylglucosamine and β-D-glucuronic acid are alternately bonded, and is a glycosaminoglucan that widely exists in connective tissues of mammals along with chondroitin sulfate and the like. It is a kind.
【0004】結合組織内でのヒアルロン酸の機能とし
て、細胞間隙に水を保持し、また組織内にジェリー状の
マトリックスを形成して細胞を保持したり、皮膚の潤滑
性と柔軟性を保ち、外力(機械的障害)および細菌感染
を防止していると考えられている。皮膚のヒアルロン酸
は齢をとるにつれて減少し、その結果小ジワやかさつき
などの老化をもたらすといわれている。従って、これを
分解するヒアルロニダーゼの活性を抑制することは、製
剤に使用されているヒアルロン酸の安定性や、皮膚に塗
布した後の製剤のヒアルロン酸及び皮膚に存在していた
ヒアルロン酸の安定に寄与すると考えられる。また、ヒ
アルロニダーゼは炎症酵素としても知られ、活性抑制す
ることは炎症を抑え、また、アレルギーにも抑制的に働
くことが知られている。As a function of hyaluronic acid in connective tissues, water is retained in the intercellular spaces, and a jelly-like matrix is formed in the tissues to retain cells, and the lubricity and flexibility of the skin are maintained. It is believed to prevent external forces (mechanical disorders) and bacterial infections. It is said that hyaluronic acid in the skin decreases with age, resulting in aging such as wrinkles and roughness. Therefore, suppressing the activity of hyaluronidase, which decomposes this, stabilizes the stability of hyaluronic acid used in the formulation and the stability of hyaluronic acid in the formulation after application to the skin and hyaluronic acid present in the skin. It is thought to contribute. Hyaluronidase is also known as an inflammatory enzyme, and it is known that suppressing the activity suppresses inflammation and also suppresses allergies.
【0005】愛玉子は学名をフィクス アウケオツァン
グ マキノ(Ficus awkeotsuang Makino)、和名をカン
テンイタビと称する植物の果実を乾燥させたものであ
る。原産地は主として台湾南部の標高1000〜200
0mに自生している高木で、台湾では水に入れてもみ、
砂糖を加えて清涼飲料として愛用されている。さらに本
発明者らによって、美白作用、保湿作用等があることを
見いだされている。[0005] Aitama is a dried fruit of a plant whose scientific name is Ficus awkeotsuang Makino and whose Japanese name is Kanten itabi. The place of origin is altitude of 1000-200 mainly in southern Taiwan
It is a tall tree that grows naturally at 0 m, and can be put in water in Taiwan.
It is used as a soft drink with added sugar. Furthermore, the present inventors have found that they have a whitening effect, a moisturizing effect, and the like.
【0006】[0006]
【発明が解決しようとする課題】本発明の目的は、人体
に対する安全性が確認されている天然物の中で肌荒れ防
止作用の強い物質を見い出し、化粧品原料として提供す
ることである。SUMMARY OF THE INVENTION An object of the present invention is to find a substance having a strong skin roughening preventive action among natural substances which have been confirmed to be safe for the human body, and provide it as a raw material for cosmetics.
【0007】[0007]
【課題を解決するための手段】本発明者らは、前記の課
題を解決するため、すでに多年にわたって食用に供さ
れ、人体に対する安全性が確認されている植物をスクリ
ーニングして調べ、肌荒れ防止剤として利用価値のある
ものを検討した。その結果、愛玉子が非常に肌荒れ防止
剤として有効性を有することを見出した。[Means for Solving the Problems] In order to solve the above-mentioned problems, the present inventors have screened and investigated plants that have been used for food for many years and have been confirmed to be safe for the human body. I examined what is useful as. As a result, they have found that love eggs are very effective as a rough skin preventive agent.
【0008】すなわち、本発明は、愛玉子の溶媒抽出物
を含む肌荒れ防止剤である。That is, the present invention is a skin roughening preventive agent containing a solvent extract of love eggs.
【0009】愛玉子の利用方法としては、水或いは親水
性有機溶媒例えば、エタノール、メタノール、アセトン
等で抽出する。しかしながら、化粧品原料の抽出である
から、水或いはエタノール或いはこれらの混合溶媒で抽
出するのが好ましいのは当然である。また、場合によっ
ては、グリセリン、1,3ブチレングリコール、プロピ
レングリコール等の多価アルコール又は多価アルコール
と水の混液も抽出に利用できる。またさらに凍結乾燥し
て粉体として利用することも利用方法によっては有効で
ある。As a method of using the egg, it is extracted with water or a hydrophilic organic solvent such as ethanol, methanol or acetone. However, since it is extraction of cosmetic raw materials, it is natural that extraction with water, ethanol or a mixed solvent thereof is preferable. In some cases, a polyhydric alcohol such as glycerin, 1,3 butylene glycol, propylene glycol or the like or a mixed liquid of polyhydric alcohol and water can be used for extraction. Further, freeze-drying and using it as powder is also effective depending on the method of use.
【0010】この物質を他の化粧品原料例えばスクワラ
ン、ホホバ油等の液状油、ミツロウ、セチルアルコール
等の固体油、各種の活性剤、グリセリン、1,3ブチレ
ングリコール等の保湿剤や各種薬剤等を添加してさまざ
まな剤形の化粧料を調整することができる。例えばロー
ション、クリーム、乳液、パック等で目的に応じて利用
形態を考えればよい。This substance is used as a raw material for other cosmetics, for example, liquid oils such as squalane and jojoba oil, solid oils such as beeswax and cetyl alcohol, various activators, moisturizing agents such as glycerin and 1,3 butylene glycol, and various agents. It can be added to adjust various dosage forms of cosmetics. For example, a lotion, a cream, a milky lotion, a pack, or the like may be used depending on the purpose.
【0011】[0011]
【実施例】以下に実際の利用方法である実施例を記載す
るが、本発明はこの実施例によって何ら限定されるもの
ではない。本発明で使用した愛玉子の抽出物の実施例を
次に示す。EXAMPLE An example of an actual usage will be described below, but the present invention is not limited to this example. Examples of the extract of love eggs used in the present invention are shown below.
【0012】(実施例1)愛玉子の種子(乾燥品)を3
0gに75%エタノール300mlを加えて時々攪拌しつ
つ5日間放置した。これを濾過後凍結乾燥した。(Example 1) 3 seeds (dried product) of love eggs
300 ml of 75% ethanol was added to 0 g and left for 5 days with occasional stirring. This was filtered and freeze-dried.
【0013】(実施例2) ローション オリーブ油 0.5 実施例1の75%エタノール抽出物 0.5 ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 2.0 エタノール 10.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 精製水 80.0(Example 2) Lotion Olive oil 0.5 75% ethanol extract of Example 1 0.5 Polyoxyethylene (20 E.O.) sorbitan monostearate 2.0 Polyoxyethylene (60 E.O.) Hydrogenated castor oil 2.0 Ethanol 10.0 1.0% sodium hyaluronate aqueous solution 5.0 Purified water 80.0
【0014】(実施例3) クリーム A スクワラン 20.0 オリーブ油 2.0 ミンク油 1.0 ホホバ油 5.0 ミツロウ 5.0 セトステアリルアルコール 2.0 グリセリンモノステアレート 1.0 ソルビタンモノステアレート 2.0 実施例1の75%エタノール抽出物 1.0 B 精製水 47.9 ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0 グリセリン 5.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 パラオキシ安息香酸メチル 0.1 AとBをそれぞれ計量し、70℃まで加温し、BにAを
攪拌しつつ徐々に加えたのち、ゆっくり攪拌しつつ30
℃まで冷却した。(Example 3) Cream A Squalane 20.0 Olive oil 2.0 Mink oil 1.0 Jojoba oil 5.0 Beeswax 5.0 Cetostearyl alcohol 2.0 Glycerin monostearate 1.0 Sorbitan monostearate 2 .0 75% ethanol extract of Example 1 1.0 B Purified water 47.9 Polyoxyethylene (20 E.O.) sorbitan monostearate 2.0 Polyoxyethylene (60 E.O.) hydrogenated castor oil 1. 0 Glycerin 5.0 1.0% sodium hyaluronate aqueous solution 5.0 Methyl paraoxybenzoate 0.1 A and B were respectively weighed, heated to 70 ° C., and A was gradually added to B with stirring. , Stirring slowly, 30
Cooled to ° C.
【0015】(抗酸化試験)以下の試験液をネジキャッ
プ付50ml試験管に作成した。 検 体 5mg 2%リノール酸エタノール溶液 10ml 0.1M,pH7.0リン酸緩衝液 10ml 精製水 5ml これを50℃の恒温槽に遮光して放置する。これを恒温
槽に入れる前と、数日おきに測定した。試験液0.12
5ml、75%エタノール12.125ml、30%チオシ
アン酸アンモニウム0.125mlを加えて攪拌し3分間
放置後、0.02N塩化第一鉄3.5%HCl水溶液
0.125mlを加えて攪拌し3分間放置後波長500nm
で吸光度を測定した。セル長10mm、対照セルは試験液
を水に置き換えたもの。(Antioxidant test) The following test solutions were prepared in 50 ml test tubes with screw caps. Specimen 5 mg 2% ethanol solution of linoleic acid 10 ml 0.1M, pH 7.0 phosphate buffer 10 ml purified water 5 ml This is left in a thermostat bath at 50 ° C while being shielded from light. It was measured before it was placed in a constant temperature bath and every few days. Test solution 0.12
5 ml, 12.25 ml of 75% ethanol and 0.125 ml of 30% ammonium thiocyanate were added and stirred for 3 minutes, after which 0.125 ml of 0.02N ferrous chloride 3.5% HCl aqueous solution was added and stirred for 3 minutes. Wavelength after leaving 500nm
The absorbance was measured with. The cell length is 10 mm, and the control cell has the test solution replaced with water.
【0016】[0016]
【表1】 [Table 1]
【0017】(ヒアルロニダーゼ活性抑制試験) (試験方法)0.4%ヒアルロン酸ナトリウム0.1M
(pH6.0)リン酸緩衝溶液を6gはかりとり、37
℃の恒温水槽で5分間放置後、前記実施例1(凍結乾燥
品)の0.1wt/v%水溶液(溶解しにくい場合はエタノ
ールを加えて溶解したのち精製水を加えて、エバポレー
トし、エタノールを除去したのち、0.1wt/v%になる
ように調製した)1.0mlを加え攪拌し、0.01%ヒ
アルロニダーゼ(シグマ社製牛睾丸製、タイプI−S)
0.1M(pH6.0)リン酸緩衝溶液を1ml加えて直
ちに攪拌し、6gを37℃の恒温水槽に入れたオストワ
ルド粘度計に入れた。これを1分後、5分後、10分
後、20分後、40分後に粘度を測定した。対照とし
て、上記試料液のかわりに純水を加え同様に測定した。
この試験では試料の終濃度は0.0125%となる。1
分後の粘度を100として、結果を指数で表2に示す。(Hyaluronidase activity inhibition test) (Test method) 0.4% sodium hyaluronate 0.1M
(PH 6.0) Weigh 6 g of phosphate buffer solution, and
After standing in a constant temperature water bath at ℃ for 5 minutes, 0.1 wt / v% aqueous solution of the above Example 1 (freeze-dried product) (if it is difficult to dissolve, add ethanol and dissolve, then add purified water and evaporate Was added to 1.0 wt / v%) and 1.0 ml was added and stirred, and 0.01% hyaluronidase (manufactured by Sigma Beef Testicle, Type I-S) was added.
1 ml of 0.1 M (pH 6.0) phosphate buffer solution was added and immediately stirred, and 6 g was placed in an Ostwald viscometer placed in a constant temperature water bath at 37 ° C. The viscosity was measured after 1 minute, 5 minutes, 10 minutes, 20 minutes, and 40 minutes. As a control, pure water was added instead of the sample solution and the same measurement was performed.
In this test, the final concentration of the sample is 0.0125%. 1
The results are shown in Table 2 as an index, with the viscosity after 100 minutes being 100.
【0018】[0018]
【表2】 [Table 2]
【0019】(使用テスト)女性6名の顔面を左右に分
け、一方の面に実施例2のローション、と実施例3のク
リームを使用し、もう一方の面に比較例1として、実施
例2の抽出物を水にかえたローションと、比較例2とし
て実施例3の抽出物を水にかえたクリームを使用しても
らって、3月後、アンケートした。(Use test) The faces of 6 women were divided into right and left, the lotion of Example 2 and the cream of Example 3 were used on one side, and the other side was used as Comparative Example 1 as Example 2. A lotion in which the extract of Example 3 was replaced with water and a cream of Comparative Example 2 in which the extract of Example 3 was replaced with water were used, and a questionnaire was conducted 3 months later.
【0020】判定基準は以下のようでアンケートの結果
をまとめたのが以下の表3である。 実施例の方が非常によい 3 実施例の方がかなりよい 2 実施例の方がややよい 1 差がない 0 比較例の方がややよい −1 比較例の方がかなりよい −2 比較例の方が非常によい −3The judgment criteria are as follows, and the results of the questionnaire are summarized in Table 3 below. Example is very good 3 Example is considerably good 2 Example is slightly good 1 No difference 0 Comparative example is good −1 Comparative example is good −2 Comparative example Is very good -3
【0021】[0021]
【表3】 [Table 3]
【0022】[0022]
【発明の効果】本発明の愛玉子の溶媒抽出物は、酸化防
止作用が強く、ヒアルロニダーゼ活性を抑制する力が強
いので、化粧品として配合すると、肌荒れを防止し、小
皺を防止し、しっとり感がまし、肌のはりを保ち、肌の
つやをよくする。長年、清涼飲料として愛用されている
ので、人間の肌に対する安全性は保証されている。The solvent extract of love egg of the present invention has a strong antioxidative effect and a strong inhibitory effect on hyaluronidase activity. Therefore, when incorporated as a cosmetic, it prevents rough skin, prevents wrinkles and gives a moist feeling. Furthermore, it maintains the elasticity of the skin and improves the luster of the skin. Since it has been used as a soft drink for many years, its safety to human skin is guaranteed.
Claims (1)
剤。1. A skin roughness inhibitor containing a solvent extract of love eggs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4273398A JPH06100427A (en) | 1992-09-18 | 1992-09-18 | Agent for preventing chapped skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4273398A JPH06100427A (en) | 1992-09-18 | 1992-09-18 | Agent for preventing chapped skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH06100427A true JPH06100427A (en) | 1994-04-12 |
Family
ID=17527345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4273398A Pending JPH06100427A (en) | 1992-09-18 | 1992-09-18 | Agent for preventing chapped skin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH06100427A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2854075A1 (en) * | 2003-04-23 | 2004-10-29 | Greentech Sa | Preparation of fig extract, useful in therapeutic or cosmetic treatment of skin, includes grinding in aqueous solution, decoloration with charcoal, concentration and precipitation with alcohol |
| JP2006069954A (en) * | 2004-09-01 | 2006-03-16 | Maruzen Pharmaceut Co Ltd | Tyrosinase activity inhibitor, skin whitening agent and skin cosmetic |
-
1992
- 1992-09-18 JP JP4273398A patent/JPH06100427A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2854075A1 (en) * | 2003-04-23 | 2004-10-29 | Greentech Sa | Preparation of fig extract, useful in therapeutic or cosmetic treatment of skin, includes grinding in aqueous solution, decoloration with charcoal, concentration and precipitation with alcohol |
| JP2006069954A (en) * | 2004-09-01 | 2006-03-16 | Maruzen Pharmaceut Co Ltd | Tyrosinase activity inhibitor, skin whitening agent and skin cosmetic |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3807782B2 (en) | Hyaluronidase inhibitor | |
| KR101737446B1 (en) | Cosmetic Composition For Skin Moisturizing | |
| JP3193441B2 (en) | Whitening cosmetics | |
| KR101458887B1 (en) | Composition for improving skin condition containing the complex extracts of Pachyrhizus erosus, Brassica oleracea L. var botrytis, Malva sinensis var. mauritiana Mill. and Cetraria islandica | |
| CN120154554A (en) | A skin-lightening composition containing golden camellia extract and its application in preparing cosmetics suitable for dry and sensitive skin | |
| JP3558349B2 (en) | Whitening cosmetics | |
| JP3273812B2 (en) | Cosmetics | |
| JP3235922B2 (en) | Cosmetics | |
| JP3170040B2 (en) | Whitening cosmetics | |
| JPH06336422A (en) | External agent for skin | |
| JP3496967B2 (en) | Antiplasmin agent | |
| JP3667376B2 (en) | Hyaluronidase inhibitor | |
| JP3206952B2 (en) | Antioxidant | |
| JP3233504B2 (en) | Cosmetics | |
| CN117159400B (en) | A composition comprising cosmetic containing the composition | |
| CN113398043A (en) | Composite hermetia illucens oil composition and application thereof | |
| JPH06100427A (en) | Agent for preventing chapped skin | |
| JPH07118135A (en) | Cosmetic | |
| JP3233462B2 (en) | Antioxidant | |
| JPH05306215A (en) | Cosmetic | |
| JPH0665043A (en) | Skin external preparation | |
| JP3461921B2 (en) | Cosmetics | |
| KR102910271B1 (en) | Cosmetic Composition of Water in Oil Type For Soothing Skin Comprising Copaifera Officinalis Resin and Passiflora Edulis Seed Oil As Active Ingredient | |
| RU2845874C1 (en) | Multifunctional cosmetic composition for lotion pads | |
| JP3408339B2 (en) | Cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Effective date: 20050106 Free format text: JAPANESE INTERMEDIATE CODE: A621 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070712 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20070724 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20071120 |